Matthew M. Walsh - Aug 5, 2022 Form 4 Insider Report for Organon & Co. (OGN)

Role: Chief Financial Officer
Signature: /s/ Tarnetta V. Jones, as Attorney-in-Fact for Matthew M. Walsh
Stock symbol: OGN
Transactions as of: Aug 5, 2022
Transactions value $: -$349,704
Form type: 4
Date filed: 8/9/2022, 07:52 PM
Previous filing: May 18, 2022
Next filing: Nov 15, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OGN	Common Stock	Options Exercise		+22.3K	+110.87%		42.5K	Aug 5, 2022	Direct	F1
transaction	OGN	Common Stock	Tax liability	-$350K	-10.8K	-25.39%	$32.41	31.7K	Aug 5, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGN	Restricted Stock Units	Options Exercise	$0	-22.3K	-50%	$0.00	22.3K	Aug 5, 2022	Common Stock	22.3K		Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.
F2	The total amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations.
F3	On each of August 5, 2021 and August 5, 2022, one-third of the RSUs vested with the remaining RSUs to vest in one final installment on August 5, 2023.